A new study reveals top factors tied to record-setting mortality rates in Canada’s LTC facilities during the early pandemic, and a treatment that boosted survival in severely ill residents.
Clinical briefs for Tuesday, August 2
By
Alicia Lasek (f3)
Aug 02, 2022
COVID-19 vaccination mandates don’t negatively affect nursing home staffing: study … ‘First-ever’ legislation to end Parkinson’s disease introduced in House … Shingles virus may cause damage...
Clinical briefs for Thursday, July 28
By
Alicia Lasek (f3)
Jul 28, 2022
Study details how COVID outbreaks led to lasting staff loss in nursing homes — and poses solutions … McKnight’s podcast: Why LTC providers must embrace more palliative care … Thursday’s CDC...
Infection preventionists join ranks of the burned-out, survey finds
By
Alicia Lasek (f3)
Jul 15, 2022
The reduced well-being of these workers impacts healthcare quality and safety in a time when there is a 25% IP job vacancy rate.
Nursing home COVID-19 infections quadruple as booster rate slows
By
Alicia Lasek (f3)
Jun 21, 2022
An AARP analysis shows a sharp uptick in infections between mid-April and mid-May, while residents’ booster shots have slowed to a trickle.
Odds of COVID-19 low in SNF post-acute care admissions: study
By
Alicia Lasek (f3)
Jun 10, 2022
Post-acute patients transferred to skilled nursing facilities in 2020 had a relatively low risk of COVID-19 infection, researchers say.
Geriatricians weigh value of newer advance care directives for nursing home residents
By
Alicia Lasek (f3)
Jun 02, 2022
In a new editorial, specialists ask whether Physician Orders for Life-Sustaining Treatment lead to high-quality care for residents.
OIG: Older Medicare recipients often harmed during hospital stays
May 13, 2022
Fully 25% of older American Medicare beneficiaries are at high risk of being harmed during acute care stays, according to the HHS Office of the Inspector General.
CDC: Turn to Paxlovid to treat COVID-19, not steroids or antibiotics
By
Alicia Lasek (f3)
Apr 26, 2022
The agency is urging clinicians to consider the now readily available, recommended therapies such as Paxlovid as first-line COVID-19 treatments.